Clinical Trial Update: A Trial Looking at Ofatumumab for People With Chronic Lymphocytic Leukaemia Who Cannot Have More Intensive Treatment [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating Ofatumumab for chronic lymphocytic leukemia patients who cannot receive more intensive treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Ofatumumab (ofatumumab)

Snippet

Sponsor: University of Liverpool | Conditions: Chronic Lymphocytic Leukaemia | Phase 3 | Status: UNKNOWN